Concerning imported cases of cholera in the city of Almaty, Kazakhstan, 2017

In 2017, from October 15 to November 21, 5 cholera cases imported from India – 3 patients and 2 carriers of V. cholerae – were recorded in Almaty. The patients recovered from the disease. Objective of the study was to characterize the imported cases of cholera and investigate the properties of cholera vibrio strains isolated from patients and carriers of V. cholerae. Materials and methods. Revised were the medical records; blood sera, feces from patients and contact persons were assayed. Studied were sensitivity spectrum to antibacterial preparations of isolated V. cholerae strains according to the “Methodological guidelines on laboratory diagnosis of cholera”, dated September 27, 2010; No 252. Epidemiological, microbiological, immunological and molecular-genetic methods were applied for investigation. Results and conclusions. Consequently to molecular genetic studies, genes of specificity, wbeN and toxicity (epidemic significance), ctxA, tcpA were detected in samples from 3 patients and 2 contact persons. The isolated strains were identified as Vibrio cholerae O1 Eltor Inaba in two cases, and in one case – as Vibrio cholerae O1 Eltor Hykoshima, Heiberg group I, toxigenic, hemolysis negative in Greig test, virulent, highly sensitive to ciprofloxacin, doxycilin, erythromycin, tetracycline and moderately sensitive to levomycetin. It was established that the country of export in all the cases was India. Relevant anti-epidemic and preventive measures were undertaken to localize and eradicate the foci in order to prevent possible threat of epidemic spread of infections among the population.

1. Grazhdanov A.K., Kozhanova O.I., Toporkov A.V., Ayazbaev T.Z., Matveeva N.I., Karnaukhov I.G., Popov N.V., Razdorsky A.S., Arkhipova G.N. [Comparative analysis of particularly dangerous infections manifestations in the territory of the Saratov and WestKazakhstan Regions with a view to advanced epidemiological risk assessment]. Problemy Osobo Opasnykh Infektsii. 2013; 4:16–23. DOI: 10.21055/0370-1069-2013-4-16-23.

2. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoints of minimum inhibitory concentrations and growth inhibition zone diameters for interpretation of results of tests for susceptibility. Version 8.0, in place since January 01, 2018 (Cited 20 Jun 2018). [Internet]. Available from:: http://www.antibiotic.ru/iacmac/ru/docs/eucast/eucast-clinical-breakpoints-bacteria-8.0-rus.pdf.

3. Kul’baeva M.M., Ismailova A.O., Sagiev Z.A., Alybaev S.D., Musagalieva R.S. [Sensitivity to anti-microbial preparations of V. cholerae strains isolated from humans and ambient environment objects in Kazakhstan in 1982-2015]. In: Relevant Issues of Modern Medicine: Proceedings of the II International Conference of the Caspian Sea Region countries (Astrakhan, October 5-6, 2017). Astrakhan: Publishing House of the Astrakhan State Medical University, 2017. 238 p.

4. [International Health Regulations]. 3rd Edition. WHO; 2016. 92 p. (Cited 15 Jun 2018). [Internet]. Available from: http://www.who.int/ihr/publications/9789241580496/ru/

5. [Methodological Regulations on Laboratory Diagnostics of Cholera]. Supplement to the Order of the Chairman of the Committee for State Sanitary-Epidemiological Surveillance, Ministry of Health of the Republic of Kazakhstan, dated September 27, 2010. No 252. (Cited 13 Jun 2018). [Internet]. Available from: http://online.zakon.kz/Document/?doc_id=31084558#pos=0;294.3999938964844.

6. Moskvitina E.A., Tyuleneva E.G., Kruglikov V.D., Titova S.V., Vodop’yanov A.S., Kurilenko M.L., Pakskina N.D., Ivanova S.M., Anisimova G.B., Vodop’yanov S.O., Oleynikov I.P. [Cholera: assessment of epidemiological situation on cholera around the world and in Russia in 2008–2017. Forecast for 2018]. Problemy Osobo Opasnykh Infektsii. 2018; 1:36–43. DOI: 10.21055/0370-1069-2018-1-36-43

7. Moskvitina E.A., Tyuleneva E.G., Samorodova A.V., Kruglikov V.D., Titova S.V., Ivanova S.M., Kovaleva T.V., Anisimova G.B. [Epidemiological situation on cholera across the globe and in the Russian Federation in 2007–2016. Forecast for 2017]. Problemy Osobo Opasnykh Infektsii. 2017; 1:13–20. DOI: 10.21055/0370-1069-2018-1-36-43.

8. Musagalieva R.S.Atshabar B.B., Sagymbek U.A., Zholshorinov A.Zh., Zhumadilova Z.B., Sagiev Z.A., Kasenova A.K., Ismailova A.O., Zhunusova G.S., Zholdasbekova A.S., Sailaubek R.S., Rakhimov K.R., Atovullaeva L.M., Aliev D.S., Medetov Zh.B. [Epidemiological situation on cholera in the Republic of Kazakhstan in 2011]. Bulletin of the East-Siberian Scientific Center of Siberian Branch, RAMS. 2012; 5(87):106–8.

9. Utepova I.B., Sagiev Z.A., Alybaev S.D., Kul’baeva M.M., Ismailova A.O., Abdirasilova A.A., Zhunusova A.S., Aldibekova A.A., Karymsakova N.T., Ismakova A.M. [Characteristics of cholera vibrio strains isolated in the territory of Kazakhstan]. Acta Biomedica Scientifica. 2017; 2(5):100–5. DOI: 10.12737/article_59e8597494f893.97278235.

10. Aikimbayev A.M., Bekenov J.Y., Meka-Mechenko T.V., Temiraliyeva G.A. The Epidemiological Surveillance of Highly Pathogenic Diseases in Kazakhstan. In: O'Connell K.P., Skowronski E.W., Bakanidze L., Sulakvelidze A., editors. Emerging and Endemic Pathogens. Springer Science + Business Media B.V.; 2010. P. 15–20. DOI: 10.1007/978-90-481-9637-1_2 www.springer.com/cda/content/document/cda.

11. Ending Cholera – A Global Roadmap to 2030. (Cited 18 Jun 2018) [Internet]. Available from: http://www.who.int/cholera/publications/global-roadmap/en/.

12. World health statistics 2018: monitoring health for the SDGs, sustainable development goals. WHO; 2018. 86 p. ISBN 978-92-4-156558-5.